First Patient Enrolled; Study Potentially To Benefit Thousands of Arizona Patients
Abrazo Health Care’s Clinical & Translational Research Institute announced today the enrollment of Arizona’s first patient in a cutting-edge clinical research trial that has potential to positively impact thousands of peripheral artery disease (PAD) patients. ... |